Literature DB >> 10936802

Role of sodium in hemodialysis.

M J Flanigan1.   

Abstract

Sodium chloride is the most abundant salt in extracellular fluid. In normal individuals, the tonicity exerted by dissolved sodium chloride determines plasma osmolality and indirectly determines intracellular tonicity and cell volume. Uremic patients retain nitrogenous wastes and have an elevated plasma osmolality. While urea exhibits osmotic activity in serum, no sustained gradient can be established across cell boundaries because it readily diffuses through cell membranes. Thus, sodium remains the major indicator of body tonicity and determines the distribution of water across the intracellular-extracellular boundary, subsequent cell volume, thirst, and, among patients with renal insufficiency, systemic blood pressure. As a result of highly conserved plasma tonicity control systems, uremic subjects demonstrate remarkable stability of their serum sodium. Dialysate is a synthetic interstitial fluid capable of reconstituting extracellular fluid composition through urea extraction and extremely efficient solute and solvent (salt and water) transfer to the patient. Subtle transdialyzer gradients deliver and remove large quantities of trace elements, solvent, and solute to patients, creating a variety of dialysis "disequilibrium" syndromes manifest as cellular and systemic distress. Every dialysis patient uses dialysate, and the most abundant chemicals in dialysate are salt and water. Despite its universal use, no consensus on dialysate composition or tonicity exists. This can only be explained if we believe that dialysate composition is best determined by matching unique dialysis delivery system characteristics to specific patient requirements. Such a paradigm treats dialysate as a drug and the dialysis system as a delivery device. Understanding the therapeutic and toxic profiles of this drug (dialysate) and its delivery device (the dialyzer) is important to safe, effective, goal-directed modifications of therapy. This article explores some of the historical rationale behind choosing specific dialysate tonicities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936802     DOI: 10.1046/j.1523-1755.2000.07609.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  19 in total

1.  Sodium modeling attenuates rises in whole-blood viscosity during chronic hemodialysis in children with large inter-dialytic weight gain.

Authors:  Sahar A Fathallah-Shaykh; Ellen R Brooks; Craig B Langman; Kenneth R Kensey
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

Review 2.  The growing problem of intradialytic hypertension.

Authors:  Francesco Locatelli; Andrea Cavalli; Benedetta Tucci
Journal:  Nat Rev Nephrol       Date:  2009-11-24       Impact factor: 28.314

3.  Dialysate sodium, serum sodium and mortality in maintenance hemodialysis.

Authors:  Finnian R Mc Causland; Steven M Brunelli; Sushrut S Waikar
Journal:  Nephrol Dial Transplant       Date:  2011-09-02       Impact factor: 5.992

Review 4.  Dialysate Sodium: Rationale for Evolution over Time.

Authors:  Jennifer E Flythe; Finnian R Mc Causland
Journal:  Semin Dial       Date:  2017-01-08       Impact factor: 3.455

5.  Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality.

Authors:  Manfred Hecking; Angelo Karaboyas; Rajiv Saran; Ananda Sen; Masaaki Inaba; Hugh Rayner; Walter H Hörl; Ronald L Pisoni; Bruce M Robinson; Gere Sunder-Plassmann; Friedrich K Port
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 8.237

6.  Individualized reduction in dialysate sodium in conventional in-center hemodialysis.

Authors:  Rohini Arramreddy; Sumi J Sun; Jair Munoz Mendoza; Glenn M Chertow; Brigitte Schiller
Journal:  Hemodial Int       Date:  2012-05-04       Impact factor: 1.812

7.  Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: a quality improvement study.

Authors:  Jair Munoz Mendoza; Liz Y Bayes; Sumi Sun; Sheila Doss; Brigitte Schiller
Journal:  Am J Kidney Dis       Date:  2011-08-27       Impact factor: 8.860

8.  Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?

Authors:  Jair Munoz Mendoza; Sumi Sun; Glenn M Chertow; John Moran; Sheila Doss; Brigitte Schiller
Journal:  Nephrol Dial Transplant       Date:  2011-02-08       Impact factor: 5.992

9.  Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation.

Authors:  Finnian R Mc Causland; Lisa M Prior; Eliot Heher; Sushrut S Waikar
Journal:  Am J Nephrol       Date:  2012-07-26       Impact factor: 3.754

Review 10.  Optimal blood pressure level and best measurement procedure in hemodialysis patients.

Authors:  Annie Saint-Remy; Jean-Marie Krzesinski
Journal:  Vasc Health Risk Manag       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.